Anticonvulsant effect of FS-1 subfraction isolated from roots of Delphinim denudatum on hippocampal pyramidal neurons

Phytotherapy Research

Volumn 17, Issue 1, 2003, Pages 38-43

  Raza, Mohsin ^a,c   Shaheen, Farzana ^b   Choudhary, M I ^b   Rahman, Atta ur ^b   Sombati, Sompong ^a   Suria, Amin ^c   Rafiq, Azhar ^a   DeLorenzo, R J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Delphinium denudatum anticonvulsant activity; FS 1 fraction; Sustained repetitive firing hippocampus

Indexed keywords

DELPHINIM DENUDATUM EXTRACT; PHENYTOIN; PLANT EXTRACT; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DELPHINIM DENUDATUM; DEPOLARIZATION; DRUG BINDING; HYPERPOLARIZATION; MEMBRANE POTENTIAL; NERVE CELL CULTURE; NERVE CONDUCTION; NERVE POTENTIAL; NEWBORN; NONHUMAN; PLANT; PLANT ROOT; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; ANTICONVULSANTS; DELPHINIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; EPILEPSY; HIPPOCAMPUS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY;

DELPHINIUM;

EID: 0037272498     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1072     Document Type: Article

References (47)

1. Abney ER, Bartlett PB, Raff MC. 1981. Astrocytes, ependymal cells and oligodendrocytes develop on schedule in dissociated cultures of embryonic rat brain. Develop Biol 83:301-310.
2. Banker GA, Cowan WM. 1977. Further observations on hippocampal neurons in dispersed cell cultures. J Comp Neurol 187: 469-494.
3. Cheung H, Kamp D, Harris E. 1992. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13: 107-112.
4. Courtney KR. 1975. Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA 968. J Pharmacol Exp Ther 195: 225-236.
5. Courtney KR, Etter EF. 1983. Modulated anticonvulsant block of sodium channels in nerve and muscle. Eur J Pharmacol 88: 1-9.
6. Cragg GM, Newman DJ, Snader KM. 1997. Natural products in drug discovery and development. J Nat Prod60: 52-60.
7. DeLorenzo RJ, Sombati S, Coulter DA. 2000. Effects of topiramate on sustained repetitive firing and sustained bursting in cultured hippocampal neurons. Epilepsia 41: S40-S44.
8. Devinsky O. 1995. Cognitive and behavioural effects of antiepileptic drugs. Epilepsia 36(Suppl 2): S46-S65.
9. Farnsworth NR. 1994. Ethnopharmacology and drug development. In Ethnobotany and The Search for New Drugs, Ciba Foundation Symposium 185. John Wiley & Sons; Chichester, 42-59.
10. 3H] Phenytoin identifies a novel anticonvulsant-binding domain on voltage-dependent sodium channels. Mol Pharmacol 42: 1097-1103.
11. A receptor function in developing rat thalamic neurons: Whole cell recordings of GABA-mediated currents and modulation by benzodiazepines, J Neurophysiol 76: 2568-2579.
12. Hamill OP, Marty A, Neher E, Sakmann B, Sigwoth FJ. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Archiv 391: 85-100.
13. Heaney D. 1999. The pharmacoeconomics of the new antiepileptic drugs. Epilepsia 40(Suppl 8): 25-31.
14. Hille B. 1992. Mechanisms of block. In Ionic Channels of Excitable Membranes. Sinauer Associates Inc.: Massachusetts, 390-442.
15. Holmes GL. 1993. Critical issues in the treatment of epilepsy. Am J Hosp Pharm 50(Suppl 5): 85-116.
16. Macdonald RL. 1989. Antiepileptic drug actions. Epilepsia 30(Suppl 1): S19-S28.
17. Macdonald RL, Kelly KM. 1994. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 35 (Suppl 4): S41-S50.
18. Macdonald RL, Kelly KM. 1995. Antiepileptic drugs mechanisms of action. Epilepsia 36(Suppl 2): S2-S12.
19. Macdonald RL, McLean MJ. 1986. Anticonvulsant drugs: mechanisms of action. In Basic Mechanisms of the Epilepsies: Molecular and Cellular Approaches, Advances in Neurology, Vol. 44 Delgado-Escueta AV, Ward Jr AA, Woodbury DM, Porter RJ (eds) Raven Press: New York, 713-736.
20. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. 1997. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38: 859-880.
21. Mattson RH. 1995. Efficacy and adverse effects of established and new antiepileptic drugs. Epilepsia 36(Suppl 2): S13-S26.
22. McLean MJ, Macdonald RL. 1983. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J Pharmacol Exp Ther 227: 779-789.
23. McLean MJ, Macdonald RL. 1984. Limitation of high frequency repetitive firing of cultured mouse neurons by anticonvulsant drugs. Neurology 34(Suppl 1): 288.
24. McLean MJ, Macdonald RL. 1986a. Carbamazepine and 10 11-epoxycarbamazepine produce use- and voltage dependent limitation of rapidly firing action potentials of mouse central neurons in culture. J Pharmacol Exp Ther 238: 727-732.
25. McLean MJ, Macdonald RL. 1986b. Sodium valproate but not ethosuximide produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 237: 1001-1011.
26. McLean MJ, Macdonald RL. 1988. Benzodiazepines but not beta carbolines limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. J Pharmacol Exp Ther 244: 789-795.
27. Meldrum BS. 1997. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia 38(Suppl 9): S7-S15.
28. Meldrum BS. 1996. Update on the mechanism of action of antiepileptic drugs. Epilepsia 37(Suppl 6): S4-S11.
29. Raza M, Shaheen F, Choudhary MI et al. 2001. Anticonvulsant activities of FS-1 subfraction isolated from roots of Dephinium denudatum. Phytother Res 15: 1-5.
30. Raza M, Sombati S, Shaheen F, Choudhary MI, DeLorenzo RJ. 1997. Anticonvulsant effects in vivo and inhibition of neuronal excitability in vitro with aqueous fraction of Delphinium denudatum. Soc Neurosci Abs 23: 840.15.
31. Rho JM, Sanker R. 1999. The pharmacologic basis of antiepileptic drug action. Epilepsia 40: 1471-1483.
32. Said HM (ed.) 1970. Hamdard Pharmacopoeia of Eastern Medicine. Hamdard National Foundation; Times Press Karachi, Pakistan, 49.
33. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. 1999. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46: 739-746.
34. Sander JW. 1998. New drugs for epilepsy. Curr Opin Neurol 11: 141-148.
35. Sander JW, Shorvon SD. 1996. Epidemiology of epilepsies. J Neurol Neurosurg Psychiat 61: 433-443.
36. Senanyake N, Roman GC. 1993. Epidemiology of epilepsies in developing countries. Bull WHO 71: 247-258.
37. Skerrit JH, Rock DM, McLean MJ, Macdonald RL. 1984a. Concentration-dependent effects of benzodiazepines on GABA responses and sustained high frequency repetitive firing in cultured neurons. Soc Neurosci Abs 10: 643.
38. Skerrit JH, Werz MA, McLean MJ, Macdonald RL. 1984b. Diazepam and its anomalous p- chloro-derivative Ro 5-4864: comparative effects on mouse neurons in cell culture. Brain Res 310: 99-105.
39. Smith MC, Bleck TP. 1991. Convulsive disorders: toxicity of anticonvulsants. Clin Neuropharmacol 14: 97-115.
40. Tomaselli GF, Marban E, Yellen G. 1989. Sodium channels from human brain RNA expressed in Xenopus oocytes. Brain electrophysiologic characteristics and their modification by diphenylhydantoin. J Clin Invest 83: 1724-1732.
41. Wamil AW, Cheung H, Harris EW, McLean MJ. 1996. Remacemide HCI and its metabolite FPL 12495AA limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell cultures. Epilepsy Res 23: 1-14.
42. Wamil AW, McLean MJ. 1994. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in culture. Epilepsy Res 17: 1-11.
43. Wamil AW, Schmutz M, Portet C, Feldmann KF, McLean MJ. 1994. Effects of oxycarbazepine and 10-hydroxycarbazepine on action potential firing and generalized seizures. Eur J Pharmacol 271: 301-308.
44. White HS. 1999. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia 40(Suppl 5): S2-S10.
45. White HS, Wolf HH, Swinyard EA, Skeen GA, Sofia RD. 1992. A neuropharmacological evaluation of felbamate as a novel anticonvulsant. Epilepsia 33: 564-572.
46. 3H]batrachotoxin A 20 benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 22: 627-635.
47. Willow M, Kuenzel EA, Catterall WA. 1984. Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 25: 228-234.